OPKO Health Inc. (OPK)
1.42
0.00 (0.35%)
At close: Apr 14, 2025, 3:59 PM
1.42
0.00%
After-hours: Apr 14, 2025, 07:53 PM EDT
0.35% (1D)
| Bid | 1.4 |
| Market Cap | 953.6M |
| Revenue (ttm) | 713.14M |
| Net Income (ttm) | -53.22M |
| EPS (ttm) | -0.08 |
| PE Ratio (ttm) | -17.75 |
| Forward PE | -5.17 |
| Analyst | Buy |
| Ask | 1.47 |
| Volume | 2,048,060 |
| Avg. Volume (20D) | 5,027,511 |
| Open | 1.43 |
| Previous Close | 1.42 |
| Day's Range | 1.41 - 1.46 |
| 52-Week Range | 1.15 - 2.04 |
| Beta | 1.79 |
About OPK
OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, geneti...
Industry Medical - Diagnostics & Research
Sector Healthcare
IPO Date Nov 2, 1995
Employees 2,997
Stock Exchange NASDAQ
Ticker Symbol OPK
Website https://www.opko.com
Analyst Forecast
According to 3 analyst ratings, the average rating for OPK stock is "Buy." The 12-month stock price forecast is $3, which is an increase of 111.27% from the latest price.
Stock ForecastsNext Earnings Release
OPKO Health Inc. is scheduled to release its earnings on May 6, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 months ago
+4.14%
Merck & Compnay and OPKO Health shares are trading...
Unlock content with
Pro Subscription
8 months ago
+11.72%
OPKO Health shares are trading higher after the company reported better-than-expected Q2 EPS results.
